Subcellular localisation of cyclin B, Cdc2 and p21WAF1/CIP1 in breast cancer: association with prognosis

« Previous Next »European Journal of Cancer
Volume 37, Issue 18 , Pages 2405-2412, December 2001

Subcellular localisation of cyclin B, Cdc2 and p21^WAF1/CIP1 in breast cancer:

Z.E Winters
- Imperial Cancer Research Fund Molecular Oncology Laboratory, University of Oxford Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, UK
- Current address: University Division of Surgery, Bristol Royal Infirmary, Marlborough Street, Bristol BS2 8HW, UK.
N.C Hunt
- Nuffield Department of Pathology, John Radcliffe Hospital, Oxford OX3 9DS, UK
M.J Bradburn
- ICRF Medical Statistics Group, John Radcliffe Hospital, Oxford OX3 9DS, UK
J.A Royds
- Department of Pathology, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK
H Turley
- Imperial Cancer Research Fund Molecular Oncology Laboratory, University of Oxford Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, UK
A.L Harris
- Imperial Cancer Research Fund Molecular Oncology Laboratory, University of Oxford Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, UK
C.J Norbury
- Imperial Cancer Research Fund Molecular Oncology Laboratory, University of Oxford Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, UK
- Corresponding author. Tel.: +44-1865-222415; fax: +44-1865-222431